Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer von HEYMACH, John V, JOHNSON, Bruce E, KENNEDY, Sarah J, HOU, Jeannie, HERBST, Roy S, PRAGER, Diane, CSADA, Edit, ROUBEC, Jaromir, PESEK, Milos, SPASOVA, Irena, BELANI, Chandra P, BODROGI, Istvdn, GADGEEL, Shirish

Volltext